Smartphone-based self-screening can identify ocular surface malignancies

AI Summary

A study demonstrates the effectiveness of smartphone-based imaging integrated with AI-driven diagnostics for self-screening and identifying rare ocular surface malignancies. This advancement merges healthcare and artificial intelligence technology.

Integration of smartphone-based imaging and artificial intelligence (AI)-driven diagnostics provides an effective strategy for screening for rare ocular malignancies, according to a study published online June 4 in JAMA Ophthalmology.